Are There Any Clinical Trials Targeting Ferroptosis in Cancer?
Clinical trials exploring ferroptosis-inducing agents are still in the early stages. However, several compounds, such as erastin and RSL3, have shown promise in preclinical models. Researchers are actively investigating the therapeutic potential of these agents and their combinations with existing cancer treatments.